Información de la revista
Descargar PDF
Más opciones de artículo
Case and Research Letter
Open Access
Pruebas no corregidas. Disponible online el 21 de Junio de 2022
The Data on Scabies Cases During COVID-19 Pandemic: A Two-Year Analysis From the Largest Portuguese Tertiary Teaching Hospital
Datos relativos a los casos de sarna durante la pandemia de COVID-19: análisis bienal realizado en el mayor hospital docente terciario de Portugal
C. Brazãoa,
Autor para correspondencia

Corresponding author.
, P. Filipea,b,c
a Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
b Dermatology and Venereology University Clinic, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
c Dermatology Research Unit, iMM João Lobo Antunes, University of Lisbon, Lisbon, Portugal
Información del artículo
Texto completo
Descargar PDF
Texto completo
Dear Editor,

Coronavirus disease 2019 (COVID-19) has affected millions of people globally since it was declared a pandemic, with plenty public health implications worldwide.1 In an attempt to contain the rapid spread of COVID-19, the Portuguese Government decided to adopt a “stay-at-home” policy, leading the population into home confinement. Although routine dermatology outpatient care was not stopped, individuals were asked to avoid visits in nonemergent conditions. Dermatology practice was inevitably affected and it is paramount that dermatologists are acquainted with possible disease pattern changes, including contagious diseases like scabies. Scabies is a skin infestation caused by Sarcoptes scabiei and transmitted by direct skin-to-skin contact.2 During the pandemic and lockdowns, it would be expected that scabies incidence would reduce due to limited contacts between individuals, especially children when face-to-face education was suspended in schools.

Our study aimed to document the impact of the pandemic on scabies diagnosis in Portugal, where the first COVID-19 case was on March 2, 2020.

A retrospective study was conducted on dermatology emergency consultations (DEC) at Hospital de Santa Maria, Lisbon, Portugal between March 2019 and February 2021. Data were analyzed independently for two consequent 12-month periods, respectively before and after the beginning of the COVID-19 pandemic in Portugal. Epidemiological variables (such as gender and age of patients) and the frequency of scabies were investigated. Diagnosis of scabies was considered definitive if clinically determined without a differential diagnosis or if confirmed by biopsy or exams. Comparative analyses between the periods before and after the first case of COVID-19 in Portugal was performed. Statistical procedures were conducted using IBM-SPSS-Statistics and MS-Excel. Pairwise comparisons (post-hoc) were performed using the z-test with correction for alpha inflation. Two-sided p-values of <0.05 were considered statistically significant.

We analyzed a total of 17880 DEC in the above-mentioned periods. We noticed a sharp reduction of 54% in the number of DEC in the 12-month period after the beginning of the pandemic in our country (5665 vs. 12215) (Table 1). In both periods, scabies diagnosis was more frequent in women (Table 1). The youngest individual diagnosed with scabies was 1 month-old and the oldest 97 years-old. The most represented age group were adults (19–64 years-old) (Table 1). The highest number of scabies diagnosis per day was 8 and this occurred in the period before COVID-19.

Table 1.

Epidemiological variables and frequency of scabies diagnosis in the study period.

  12 month-period12 month-period
  Before COVID-19 in PortugalAfter COVID-19 in Portugal
Number of DEC  122155665
Scabies cases  Number  Percentage  Number  Percentage 
Total  608  5.0%  276  4.9% 
Male  266  43.8%  120  43.5% 
Female  342  56.2%  156  56.5% 
Children (0–18 years old)  187  30.8%  55  19.9% 
Adults (19–64 years old)  349  57.4%  181  65.6% 
Elderly (>65 years old)  72  11.8%  40  14.5% 

In the 12-month period after the first case of COVID-19 in Portugal, there was a total of 276 scabies cases (4.9% of all DEC) compared to 608 (5.0%) in the previous 12-month period, with no statistically significant difference (z-score=0.303; p=0.762).

We performed a subgroup analysis to rule out a disparity in scabies cases during the first lockdown in Portugal (March 18–May 2, 2020), compared to the corresponding period of the previous year, showing no statistically significant difference (z-score=−0.619; p=0.535) (Table 2).

Table 2.

Scabies diagnosis during the first lockdown period, the corresponding period in the previous year and the 2-month period after lockdown.

  First lockdown periodLockdown corresponding period in the previous yearPost-lockdown period
Number of DEC  36014531074
Scabies cases  Number  Percentage  Number  Percentage  Number  Percentage 
Total  21  5.8%  73  5.0%  57  5.3% 
Children  42.8%  23  31.5%  21  36.8% 

Given the fact that scabies has a 4–6 week incubation period, we also analyzed the 2-month period after lockdown and there was no increase in scabies cases compared to the lockdown period (z-score=0.381; p=0.703) (Table 2). There was also no difference when comparing the first lockdown to the corresponding period in the previous year (z-score=0.158; p=0.874) or to the post-lockdown period (z-score=−0.287; p=0.775) in children (Table 2).

In our tertiary teaching hospital in Portugal, the pandemic did not seem to alter the incidence and epidemiology of scabies. Even though there was a significant decrease in overall DEC in the post pandemic period, there was no difference in the proportion of scabies cases, nor in the epidemiologic features of the disease.

Our results differ from previous reports from Spain, Italy and Turkey where there was an increase in scabies incidence during COVID-19 pandemic,3–6 as a possible consequence of temporary moving from urban to rural areas (where scabies is more common) and increasing close contact between individuals (as a result of the stay-at-home orders).3–5

One limitation of our study is that it was a single-center analysis. However, our Hospital is the largest Portuguese tertiary teaching hospital and the only one in the country with an open dermatology emergency department, and therefore receives a large amount of DEC. This provided us with a substantial sample size and therefore increases the strength of our findings.

Another limitation is that the study was retrospective and some data such as severity of disease, duration of symptoms and number of cases in cohabitants could not be obtained.

Nevertheless, our study shows that social and cultural differences among countries can lead to different disease processes. Certainly, further epidemiological studies are needed to investigate the prevalence of scabies before and during COVID-19 in order to improve our knowledge about this parasitosis and its management and prevention in particular conditions.


There are no funding sources to declare.

Conflicts of interest

There are no conflicts of interest to declare.

S.P. Kartal, G. Çelik, N. Sendur, et al.
Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey.
Dermatol Therapy, 33 (2020),
A.A. El-Moamly.
Scabies as a part of the World Health Organization roadmap for neglected tropical diseases 2021–2030: what we know and what we need to do for global control.
I. Martínez-Pallás, B. Aldea-Manrique, M. Ramírez-Lluch, J. Manuel Vinuesa-Hernando, M. Ara-Martín.
Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic.
J Eur Acad Dermatol Venereol, 34 (2020), pp. e781-e783
M. de Lucia, L. Potestio, L. Costanzo, G. Fabbrocini, L. Gallo.
Scabies outbreak during COVID-19: an Italian experience.
Int J Dermatol, 60 (2021), pp. 1307-1308
Ö. Kutlu, H. Aktaş.
The explosion in scabies cases during COVID-19 pandemic.
Dermatol Therapy, 33 (2020),
P.A. Cerro, A. Navarro-Bielsa, A.M. Palma.
FR – epidemia de sarna en el contexto de la pandemia de COVID-19.
Actas Dermo-Sifiliogr, (2021),
Copyright © 2022. AEDV
Actas Dermo-Sifiliográficas

Suscríbase a la newsletter

Opciones de artículo

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?